of semaglutide Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes PDB-101: Diabetes Mellitus: Diabetes Mellitus:

This happens over 64-68 weeks when people follow their program consistently

Semaglutide supplied by Swiss Research is intended strictly for research use only

In individuals without diabetes, these effects could disrupt normal metabolic processes and lead to hypoglycemia (low blood sugar), gastrointestinal disturbances, or other adverse reactions

That is a conversation worth having with a provider who knows both options well enough to be honest about the tradeoffs

Many patients find that anxiety diminishes substantially within 24 weeks of stabilizing at a given dose

Reach out to TruLaw for a free, no obligation consultation